Rising Pharmaceuticals admits to fixing prices
Rising Pharmaceuticals admitted to fixing prices on a medicine used to treat hypertension, the Department of Justice announced. The New Jersey-based drugmaker also entered a deferred prosecution agreement with the government....To view the full article, register now.
Already a subscriber? Click here to view full article